Description
Taylor and Francis Ltd COVID-19 and SARS-CoV-2 1st Edition 2022 Hardbound by Goswami, Srijan
Contains simple, lucid and concise presentation of contentsEmphasizes core knowledge and concepts Presents evidence based and up to date information from a multidisciplinary perspectiveIncludes illustrations with good quality diagrams and colored photographs for ease of understanding. UNIT 1: Molecular Biology of Coronaviruses and SARS-CoV-2. Coronaviruses, History, Its Classification and COVID-19. SARS-CoV-2, Morphology, Genomic Organization and Life Cycle. Molecular-Pathophysiology and Clinical Presentation of COVID-19 - The Comparison of Reductionistic and Holistic Perspective. SARS-CoV-2 and its Variants: Definitions and Classifications. UNIT 2: Conventional Treatment Strategies for COVID-19 and Associated Public Health Concerns. Epidemiology of COVID - 19. Challenges and Innovations in Mathematical Modelling of COVID-19. Immuno-Pathologic basis of COVID-19 and Management of Mild and Moderate Cases. Diagnosis of COVID-19 using Clinical Examination, Immunoassays and Molecular Diagnostic Techniques. Conventional Pharmacological strategies, Investigational Drugs and Antibody Directed Immunotherapies for COVID - 19. Research and Development of Vaccines for COVID - 19. Mucormycosis - Post COVID-19 complications in Patients with Diabetes and State of Immunosuppression. Impact of COVID-19 and Associated Aspects on Reproductive, Maternal and Child Health. UNIT 3: COVID - 19 and Supportive, Complementary and Alternative Treatment Strategies. Ayurvedic Perspective and COVID - 19. Role of Homoeopathy in Prophylaxis and Symptomatic Management of COVID - 19 Patients. Additional Short Article - Homoeopathic Practice in midst of COVID-19 - A Physician's Clinical Experience. Solving the Mystery of COVID-19: Holistic Medical Nutrition Therapy. Immunotherapeutic Role of Vitamin D as Preventive Treatment of COVID - 19 Patients. Role of Biochemic Medicines in Prophylaxis and Complementary Nutraceutical Therapy of Influenza like Illnesses or Respiratory Tract Complications (COVID-19).